HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Shen Selected Research

Lin Shen Research Topics

Disease

193Neoplasms (Cancer)
11/2022 - 05/2003
113Stomach Neoplasms (Stomach Cancer)
04/2022 - 06/2006
56Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 05/2003
28Adenocarcinoma
07/2022 - 12/2011
25Neoplasm Metastasis (Metastasis)
01/2022 - 09/2008
22Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 11/2004
19Disease Progression
01/2022 - 12/2012
18Esophageal Squamous Cell Carcinoma
10/2022 - 06/2007
17Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2022 - 05/2008
17Hypertension (High Blood Pressure)
05/2022 - 06/2008
14Spinal Cord Injuries (Spinal Cord Injury)
05/2022 - 04/2012
13Diarrhea
07/2022 - 12/2007
12Infections
09/2021 - 06/2006
11Carcinoma (Carcinomatosis)
04/2021 - 08/2004
10Breast Neoplasms (Breast Cancer)
06/2022 - 01/2011
9Microsatellite Instability
01/2022 - 01/2020
9Neutropenia
01/2021 - 05/2008
9Inflammation (Inflammations)
12/2020 - 08/2008
8Nasopharyngeal Carcinoma
01/2022 - 04/2015
8Esophageal Neoplasms (Esophageal Cancer)
04/2021 - 03/2012
8Osteoporosis
09/2020 - 09/2004
7Stroke (Strokes)
07/2022 - 01/2017
7Hepatocellular Carcinoma (Hepatoma)
04/2022 - 11/2014
7Disease Resistance
09/2021 - 02/2009
7Postmenopausal Osteoporosis
04/2019 - 08/2007
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2011
6Melanoma (Melanoma, Malignant)
01/2022 - 09/2013
5Glioma (Gliomas)
11/2022 - 11/2015
5Lymphoma (Lymphomas)
08/2022 - 08/2012
5Hypoxia (Hypoxemia)
01/2022 - 10/2014
5Lung Neoplasms (Lung Cancer)
01/2022 - 09/2013
5Fibrosis (Cirrhosis)
09/2021 - 04/2009
5Heart Failure
04/2021 - 05/2002
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2020 - 02/2008
5Body Weight (Weight, Body)
09/2014 - 04/2009
4Reperfusion Injury
01/2022 - 02/2014
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2022 - 01/2016
4Ischemia
11/2021 - 10/2015
4Circulating Neoplastic Cells
10/2021 - 11/2017
4Fatigue
02/2021 - 06/2007

Drug/Important Bio-Agent (IBA)

44Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2008
28Cisplatin (Platino)FDA LinkGeneric
05/2022 - 05/2003
28Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
27Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 06/2007
24Pharmaceutical PreparationsIBA
05/2022 - 06/2007
23Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 05/2003
22Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2010
20Trastuzumab (Herceptin)FDA Link
01/2021 - 08/2010
19Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 11/2004
19Capecitabine (Xeloda)FDA Link
01/2021 - 12/2008
18Irinotecan (Camptosar)FDA LinkGeneric
10/2022 - 12/2007
15Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 03/2008
14Biological ProductsIBA
01/2022 - 09/2004
13Cetuximab (Erbitux)FDA Link
05/2022 - 05/2008
11human ERBB2 proteinIBA
04/2022 - 08/2010
10Tyrosine Kinase InhibitorsIBA
05/2022 - 12/2011
10Sunitinib (Sutent)FDA Link
01/2022 - 12/2011
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2004
9MicroRNAs (MicroRNA)IBA
01/2022 - 03/2012
9RNA (Ribonucleic Acid)IBA
12/2021 - 06/2007
9LigandsIBA
12/2021 - 08/2007
9Leucovorin (Folinic Acid)FDA Link
08/2018 - 05/2003
8Monoclonal AntibodiesIBA
08/2022 - 08/2010
8Indicators and Reagents (Reagents)IBA
09/2021 - 03/2008
7Phosphotransferases (Kinase)IBA
05/2022 - 06/2017
7PlatinumIBA
01/2022 - 11/2013
7HMPL-013IBA
01/2022 - 01/2017
7regorafenibIBA
01/2022 - 01/2020
6ParaffinIBA
11/2022 - 08/2004
6B7-H1 AntigenIBA
10/2022 - 01/2020
6ErbB Receptors (EGF Receptor)IBA
05/2022 - 01/2011
6Therapeutic UsesIBA
01/2022 - 05/2003
6CateninsIBA
01/2020 - 01/2013
5Messenger RNA (mRNA)IBA
01/2022 - 06/2016
5pembrolizumabIBA
04/2021 - 04/2019
5Bevacizumab (Avastin)FDA Link
02/2021 - 10/2011
5Tumor Biomarkers (Tumor Markers)IBA
11/2020 - 01/2015
5Folic Acid (Vitamin M)FDA LinkGeneric
01/2017 - 09/2013
4Docetaxel (Taxotere)FDA Link
10/2022 - 01/2016
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 10/2007
4Interleukin-6 (Interleukin 6)IBA
05/2022 - 10/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
05/2022 - 11/2014
4Alanine Transaminase (SGPT)IBA
05/2022 - 12/2008
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2022 - 01/2020
4surufatinibIBA
02/2022 - 11/2020
4toripalimabIBA
02/2022 - 01/2020
4thiamine triphosphorate (TTP)IBA
01/2022 - 06/2007
4Long Noncoding RNAIBA
01/2022 - 01/2020
4EnzymesIBA
09/2021 - 06/2011
4GemcitabineFDA Link
05/2021 - 08/2007

Therapy/Procedure

105Therapeutics
10/2022 - 05/2002
98Drug Therapy (Chemotherapy)
10/2022 - 06/2007
30Immunotherapy
10/2022 - 01/2016
12Radiotherapy
08/2020 - 06/2007
8Transplantation
01/2022 - 05/2002
8Aftercare (After-Treatment)
01/2020 - 06/2006
6Neoadjuvant Therapy
01/2021 - 06/2012
5Precision Medicine
08/2021 - 02/2012
5Highly Active Antiretroviral Therapy (HAART)
02/2012 - 03/2008
4Combination Drug Therapy (Combination Chemotherapy)
08/2022 - 12/2008